Brams Matthew 4

What Happened
Matthew Brams, EVP and Chief Medical Officer of Cingulate Inc. (CING), was granted 4,526 shares of common stock on 2026-03-09 as part of a compensation award. The shares were issued at $0.00 (a compensatory grant); 1,025 of the shares were withheld to satisfy tax obligations, resulting in a net issuance of 3,501 shares to Mr. Brams. The filing shows the grant (transaction code A) and the tax withholding (transaction code F), both reported on the Form 4 filed 2026-03-11.

Key Details

• Transaction date(s): 2026-03-09 (grant and tax withholding).
• Prices reported: $0.00 per share for both the award (A) and the withheld shares (F).
• Net shares received: 4,526 granted − 1,025 withheld = 3,501 net new shares.
• Shares owned after the transaction: Not specified in the disclosed filing.
• Footnotes: F1 — grant made under the Issuer’s 2021 Omnibus Equity Incentive Plan as part of a portion of the Reporting Person’s 2025 bonus. F2 — 1,025 shares were withheld to satisfy tax obligations on the grant.
• Filing timeliness: Form 4 was filed 2026-03-11 (two days after the transaction date), which is consistent with the typical two-business-day reporting window.

Context
This was a compensatory equity grant (not an open-market purchase or sale). Tax-withholding of awarded shares (a cashless-withholding method) is common and should be viewed as a routine payroll/tax action rather than a market-driven sale. Awards signal company compensation practices but do not necessarily indicate the insider’s personal trading view of the stock.